For nonalcoholic fatty liver disease, increased hepatic Th17 cells, RORγt and IL-17 expression are observed in the progression from one subtype nonalcoholic fatty liver disease to the other subtype nonalcoholic steatohepatitis [6,7]. This evidence concerns the gene IL17A and metabolic dysfunction-associated steatotic liver disease.